Prostate specific antigen (PSA) is an established marker for prostate hypertrophy and cancer. PSA within normal limits reflects both gland hypertrophy and specific inflammation. The aim of the present study was to investigate whether PSA values, within normal levels, are associated with arterial ...
Prostate-specific antigen (PSA) levels by age remain the same across most populations. A PSA level above 4.0 ng/mL in any age group must be investigated. However, PSA levels can spike in noncancerous conditions, such as benign prostate hypertrophy (BPH), urinary tract infections, prostatitis,...
The clinical and pathological features of metastatic prostate cancer with normal level of serum prostate-specific antigen (PSA) were investigated. Four patients with metastatic prostate cancer had serum PSA within the normal range at the diagnosis. All tumors were poorly-differentiated adenocarcinoma. End...
Prostate-specific membrane antigen is a type II membrane protein with folate hydrolase activity produced by prostatic epithelium. The expression of this molecule has also been documented in extraprostatic tissues, including small bowel and brain. In the present study, an extensive immunohistochemical anal...
Prostate-specific antigen (PSA): ng/mL; no specific normal or abnormal level Miscellaneous Additional normal ranges include the following [1, 2] : Alpha 1-antitrypsin: 83-199 mg/dL Angiotensin-converting enzyme: 8–53 U/L C-reactive protein: < 0.5 mg/dL D-dimer: ≤ 300 ng/mL (...
The level of 'prostate specific antigen' (PSA) is used as a preliminary screening test for prostate cancer. 7% of men with prostate cancer do not have a high level of PSA. These results are known as ' When blood is drawn from a patient, is the result fro...
Serum prostate-specific antigen (PSA) is currently the most used biomarker in clinical practice for prostate cancer (PCa) detection. However, this biomarker has several drawbacks. In this work, an untargeted gas chromatography-mass spectrometry (GC-MS)-based metabolomic profiling of PCa cells was ...
Screenings for healthy men may include a digital rectal exam (DRE) and possibly a prostate specific antigen (PSA) blood test. Government guidelines recommend against the routine use of the PSA test. The American Cancer Society advises each man to talk with a doctor about the risks and possible...
In clinical practice, PCa is confirmed or excluded by transrectal ultrasound-targeted biopsy, based on the results of digital rectal examination or serum prostate-specific antigen (PSA) levels4, and perfusion analysis by CETRUS5. However, recent findings have demonstrated that CETRUS is of limited...
Metastasis tumor antigens, an emerg- ing family of multifaceted master coregulators. J Biol Chem 2007; 282:1529-1533. 136 Yao YL, Yang WM. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem 2003; 278:42560-42568. Cell ...